4-(2-amino-1H-benzimidazol-4-yl)-1-N-[(2R)-2,3-diaminopropyl]-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide
C17H21N11O4S2 — CID 135311053
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(2-amino-1H-benzimidazol-4-yl)-1-N-[(2R)-2,3-diaminopropyl]-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide
4-(2-amino-1H-benzimidazol-4-yl)-1-N-[(2R)-2,3-diaminopropyl]-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide (PubChem CID 135311053) has the molecular formula C17H21N11O4S2 and a molecular weight of 507.56 g/mol. Its IUPAC name is 4-(2-amino-1H-benzimidazol-4-yl)-1-N-[(2R)-2,3-diaminopropyl]-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide.
Molecular Properties
| Compound Name | 4-(2-amino-1H-benzimidazol-4-yl)-1-N-[(2R)-2,3-diaminopropyl]-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide |
|---|---|
| PubChem CID | 135311053 |
| Molecular Formula | C17H21N11O4S2 |
| Molecular Weight | 507.56 g/mol |
| Exact Mass | 507.12 |
| IUPAC Name | 4-(2-amino-1H-benzimidazol-4-yl)-1-N-[(2R)-2,3-diaminopropyl]-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide |
| SMILES | NC[C@@H](N)CNS(=O)(=O)c1ccc(-c2cccc3[nH]c(N)nc23)c(-c2nn[nH]n2)c1S(N)(=O)=O |
| InChI | InChI=1S/C17H21N11O4S2/c18-6-8(19)7-22-34(31,32)12-5-4-9(10-2-1-3-11-14(10)24-17(20)23-11)13(15(12)33(21,29)30)16-25-27-28-26-16/h1-5,8,22H,6-7,18-19H2,(H3,20,23,24)(H2,21,29,30)(H,25,26,27,28)/t8-/m1/s1 |
| InChIKey | XBTNMJXWTUCPMA-MRVPVSSYSA-N |
| XLogP | -1.80 |
| TPSA | 267.53 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 507.56 |
| LogP ≤ 5 | -1.80 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135311053 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.